These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 32622022)

  • 1. Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites.
    Cao J; Huang D; Peppas NA
    Adv Drug Deliv Rev; 2020 Dec; 167():170-188. PubMed ID: 32622022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).
    Ruiz ME; Gantner ME; Talevi A
    Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):99-128. PubMed ID: 23578193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications.
    Rajpoot K
    Curr Cancer Drug Targets; 2020; 20(4):271-287. PubMed ID: 31951180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
    Zhang J; Tang H; Liu Z; Chen B
    Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendronized Systems for the Delivery of Chemotherapeutics.
    Dockery L; Daniel MC
    Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active targeting strategies for anticancer drug nanocarriers.
    Basile L; Pignatello R; Passirani C
    Curr Drug Deliv; 2012 May; 9(3):255-68. PubMed ID: 22452402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan Nanoparticles for Targeted Cancer Therapy: A Review of Stimuli-Responsive, Passive, and Active Targeting Strategies.
    Al-Shadidi JRMH; Al-Shammari S; Al-Mutairi D; Alkhudhair D; Thu HE; Hussain Z
    Int J Nanomedicine; 2024; 19():8373-8400. PubMed ID: 39161363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stealth Nanocarriers in Cancer Therapy: a Comprehensive Review of Design, Functionality, and Clinical Applications.
    Saadh MJ; Mustafa MA; Kumar A; Alamir HTA; Kumar A; Khudair SA; Faisal A; Alubiady MHS; Jalal SS; Shafik SS; Ahmad I; Khry FAF; Abosaoda MK
    AAPS PharmSciTech; 2024 Jun; 25(6):140. PubMed ID: 38890191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of chitosan-based nanocarriers in tumor-targeted drug delivery.
    Ghaz-Jahanian MA; Abbaspour-Aghdam F; Anarjan N; Berenjian A; Jafarizadeh-Malmiri H
    Mol Biotechnol; 2015 Mar; 57(3):201-18. PubMed ID: 25385004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting.
    Bugno J; Hsu HJ; Hong S
    J Drug Target; 2015; 23(7-8):642-50. PubMed ID: 26453160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends.
    Sohail MF; Rehman M; Sarwar HS; Naveed S; Salman O; Bukhari NI; Hussain I; Webster TJ; Shahnaz G
    Int J Nanomedicine; 2018; 13():3145-3161. PubMed ID: 29922053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine in cancer therapy: innovative trends and prospects.
    Blanco E; Hsiao A; Mann AP; Landry MG; Meric-Bernstam F; Ferrari M
    Cancer Sci; 2011 Jul; 102(7):1247-52. PubMed ID: 21447010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organic nanocarriers for cancer drug delivery.
    López-Dávila V; Seifalian AM; Loizidou M
    Curr Opin Pharmacol; 2012 Aug; 12(4):414-9. PubMed ID: 22465543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-loaded nanocarriers: passive targeting and crossing of biological barriers.
    Rabanel JM; Aoun V; Elkin I; Mokhtar M; Hildgen P
    Curr Med Chem; 2012; 19(19):3070-102. PubMed ID: 22612696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of tumor microenvironment for improved delivery and intratumor distribution of nanocarriers.
    Ishida T; Kiwada H
    Biol Pharm Bull; 2013; 36(5):692-7. PubMed ID: 23649327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted nanoparticulate drug-delivery systems for treatment of solid tumors: a review.
    Bhattacharjee H; Balabathula P; Wood GC
    Ther Deliv; 2010 Nov; 1(5):713-34. PubMed ID: 22833959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micelles as potential drug delivery systems for colorectal cancer treatment.
    Fatfat Z; Fatfat M; Gali-Muhtasib H
    World J Gastroenterol; 2022 Jul; 28(25):2867-2880. PubMed ID: 35978871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor.
    Li X; Wu M; Pan L; Shi J
    Int J Nanomedicine; 2016; 11():93-105. PubMed ID: 26766908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.